Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 1;145(3):343-345.
doi: 10.1097/AOG.0000000000005846. Epub 2025 Jan 30.

Serial Total Bile Acid Measurements in Intrahepatic Cholestasis of Pregnancy

Minhazur R Sarker  1 , Gladys A Ramos, Lauren Ferrara, Chelsea A Debolt
Affiliations

Serial Total Bile Acid Measurements in Intrahepatic Cholestasis of Pregnancy

Minhazur R Sarker et al. Obstet Gynecol. .

Abstract

Although peak serum total bile acid (TBA) levels guide management of intrahepatic cholestasis of pregnancy (ICP), whether ICP progresses in severity and when or how to assess bile acid levels serially remains unclear. We conducted a secondary analysis of a single-institution retrospective cohort study to assess bile acid trends across pregnancy among individuals diagnosed with ICP and to evaluate whether there was progression to higher ICP severity. We defined ICP severity as mild (peak TBA less than 40 micromol/L), moderate (peak TBA between 40 and 100 micromol/L), or severe (peak TBA 100 micromol/L or greater). Among the 1,188 patients with ICP in our cohort, 354 (29.8%) had repeat bile acid level measurements. Of those patients, 88 (24.9%) progressed to higher ICP severity that may have resulted in changes to delivery timing. Further studies are needed to determine whether serial assessment of bile acid levels with potential reclassification of ICP severity improves outcomes.

PubMed Disclaimer

Conflict of interest statement

Financial Disclosure The authors did not report any potential conflicts of interest.

References

    1. Brouwers L, Koster MPH, Godelieve;, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol [Internet]. 2015. [cited 2022 Feb 19];212:100.e1–100.e7. Available from: 10.1016/j.ajog.2014.07.026 - DOI - PubMed
    1. Kawakita T, Parikh LI, Ramsey PS, et al. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol [Internet]. 2015;213(4):570.e1. Available from: /pmc/articles/PMC5199141/ - PMC - PubMed
    1. Rioseco AJ, Ivankovic MB, Manzur A, et al. Intrahepatic cholestasis of pregnancy: A retrospective case-control study of perinatal outcome. Am J Obstet Gynecol [Internet]. 1994;170(3):890–5. Available from: http://www.ajog.org/article/S0002937894703043/fulltext - PubMed
    1. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019. Mar 2;393(10174):899–909. - PMC - PubMed
    1. Sarker M, Zamudio AR, DeBolt C, Ferrara L. Beyond stillbirth: association of intrahepatic cholestasis of pregnancy severity and adverse outcomes. Am J Obstet Gynecol [Internet]. 2022. Sep 1 [cited 2022 Aug 28];227(3):517.e1–517.e7. Available from: http://www.ajog.org/article/S0002937822004598/fulltext - PubMed

Substances

Supplementary concepts